An anti-malware alliance is accusing Baidu
of still having a "large amount" of "rule-violating"
medical/pharmaceutical bid-ranking advertisements
in its search results, reports 163.com. The alliance
says in a report that the volume of medical/
pharmaceutical bid-ranking advertisements on
Baidu.com fell after a media expose but has since
seen a big comeback. Ads for the aforementioned
industry accounted for 36.62%, or 650,000, of
Baidu bid-ranking ads on December 14, as compared
to 27.5%, or 300,000, of total ads on November 27,
said the alliance report.